Search Results - Suvi Parviainen

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors

    Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors by Siri Tähtinen, Saija Kaikkonen, Maiju Merisalo-Soikkeli, Susanna Grönberg-Vähä-Koskela, Anna Kanerva, Suvi Parviainen, Markus Vähä‐Koskela, Akseli Hemminki

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma

    Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma by Mikko Siurala, Simona Bramante, Lotta Vassilev, Mari Hirvinen, Suvi Parviainen, Siri Tähtinen, Kilian Guse, Vincenzo Cerullo, Anna Kanerva, Anja Kipar, Markus Vähä‐Koskela, Akseli Hemminki

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

    Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma by Mikko Siurala, Riikka Havunen, Dipongkor Saha, Dave Lumén, Anu J. Airaksinen, Siri Tähtinen, Víctor Cervera-Carrascón, Simona Bramante, Suvi Parviainen, Markus Vähä‐Koskela, Anna Kanerva, Akseli Hemminki

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

    Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus by Iulia Diaconu, Vincenzo Cerullo, Mari Hirvinen, Sophie Escutenaire, Matteo Ugolini, Saila K. Pesonen, Simona Bramante, Suvi Parviainen, Anna Kanerva, Angelica Loskog, Aristides G. Eliopoulos, Sari Pesonen, Akseli Hemminki

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy

    Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy by Otto Hemminki, Suvi Parviainen, Juuso Juhila, Riku Turkki, Nina Linder, Johan Lundin, Matti Kankainen, Ari Ristimäki, Anniina Koski, Ilkka Liikanen, Minna Oksanen, Dirk M. Nettelbeck, Kalevi Kairemo, Kaarina Partanen, Timo Joensuu, Anna Kanerva, Akseli Hemminki

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: